fbpx Skip to main content

Contact Details

About Us

MD Newsline is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives.

Send us a message!

    Latest Posts

    Eblasakimab is efficacious and well-tolerated for treating adults with moderate-to-severe atopic dermatitis, according to a recent cohort study.
    Atopic dermatitis

    Safety and Efficacy of Eblasakimab in Moderate-to-Severe Atopic Dermatitis

    Eblasakimab is efficacious and well-tolerated for treating adults with moderate-to-severe atopic dermatitis, according to a…
    An artificial intelligence-based psoriasis severity assessment model may be a promising alternative for dermatologists’ assessments, according to a real-world study.
    Atopic dermatitis
    Psoriasis Severity Assessment Based on Artificial Intelligence

    Popular Posts